Neonatal growth charts

Enrico Bertino1, Paola Di Nicola, Alessia Varalda

  • 1Cattedra di Neonatologia, Dipartimento di Scienze Pediatriche e dell'Adolescenza, Università degli Studi di Torino, Torino, Italy. enrico.bertino@unito.it

Insights

Accurate neonatal growth assessment is crucial. New Italian Neonatal Study (INeS) charts offer improved neonatal anthropometric references, addressing limitations of existing growth charts for preterm infants.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Medical Statistics
  • Clinical Epidemiology

Background:

  • Recognizing abnormal growth at birth and intrauterine malnutrition is vital for neonatal care and prognosis.
  • Current neonatal auxological evaluation relies on anthropometric and intrauterine growth charts, but methodological issues limit comparability.
  • Existing charts have limitations for monitoring the postnatal growth of preterm newborns.

Purpose of the Study:

  • To produce reliable Italian neonatal anthropometric reference charts (INeS charts) meeting stringent criteria.
  • To address the need for improved growth monitoring tools for preterm infants.
  • To establish a comprehensive growth monitoring strategy for infants from birth to 20 years.

Main Methods:

  • A multicenter survey was promoted by leading Italian medical societies.
  • Development of new Italian Neonatal Study (INeS) charts for neonatal anthropometry.
  • Integration of international longitudinal charts (WHO 2006, CDC 2002) and SIEDP charts for comprehensive growth monitoring.

Main Results:

  • The INeS charts provide a reliable reference for neonatal anthropometry up to term.
  • A proposed strategy combines INeS charts, WHO/CDC charts, and SIEDP charts for continuous growth monitoring.
  • This approach aims to overcome limitations of existing charts for preterm infant growth assessment.

Conclusions:

  • The INeS charts represent a significant advancement in Italian neonatal anthropometric references.
  • A combined approach using INeS, WHO/CDC, and SIEDP charts offers a practical solution for monitoring infant growth in Italy.
  • This strategy enhances the evaluation of postnatal growth for preterm infants from birth to 20 years.

Related Concept Videos

Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
Bacterial Growth Curve01:28

Bacterial Growth Curve

The bacterial growth curve is a fundamental concept in microbiology that describes the dynamics of bacterial population growth in a closed system with controlled environmental conditions, such as temperature and nutrient availability. This curve is divided into four distinct phases: lag, log (exponential), stationary, and death phases, each reflecting a unique stage of bacterial adaptation and growth. During the lag phase, bacteria acclimate to their surroundings by synthesizing essential...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...